Abstract: Fixed-bed reactors have gained growing attention for the cultivation of mammalian cells. They allow for a low shear stress cultivation of adherent and non-adherent cells due to the immobilization of cells within macroporous carriers. Their potential has been demonstrated for many cell culture purposes. Some of the recent developments are presented in this review, including improved antibody production by hybridoma cells, high performance cultivation of a hepatoblastoma cell line and cultivation of cells for the production of retroviral vectors. Furthermore, criteria for the selection of process strategies and scale-up concepts are addressed.
INTRODUCTION
Mammalian cells are used in industry as well as in research for a variety of applications. Examples include the production of monoclonal antibodies by hybridoma cells, therapeutic and diagnostic glyco-proteins by recombinant cells, production of retroviral vectors for gene therapy, and the cultivation of tissue cells for artificial organs [1] . Even if the majority of production systems are based on stirred tank reactors, reactor systems like fixed bed reactors which allow immobilization of cells have been gaining growing attention for a number of applications [2] [3] [4] . In vivo, cells are immobilized in tissues and organs and are perfused by lymph, blood, etc. In vitro systems, immobilization is primarily used to increase the stability and process intensity of the culture. Fixed-bed reactors have shown their potential in the establishment of optimum culture conditions for many cell culture purposes. Some of the recent developments are presented here, including improved antibody production by hybridoma cells, high performance cultivation of a hepatoblastoma cell line and cultivation of cells for the production of retroviral vectors. Furthermore, criteria for the selection of process strategies and scale-up concepts are addressed.
DESIGN OF FIXED BED REACTORS
A fixed-bed reactor consists of a vessel filled or packed with carrier material used as support for the immobilization of cells, and a conditioning vessel that contains the culture medium ( Fig. 1, right) . Both units are coupled via a circulation loop through which oxygen enriched medium is pumped from the conditioning vessel through the fixed-bed and back, while the cells (adherent or non-adherent) are retained in the fixed-bed. In the conditioning vessel, the exhausted productcontaining medium is exchanged batch wise or continuously [2] . An axial pumping of the media through the fixed-bed provides the cells with fresh media and oxygen upto fixedbed lengths of approx. 15 cm. Due to possible oxygen limitation, larger fixed-bed volumes require the medium flow *Address correspondence to this author at the Institute of Bioprocess and Biosystems Engineering, Hamburg University of Technology, Germany; Email: poertner@tuhh.de through the bed to be radial (Fig. 1, left) [5] [6] [7] [8] [9] [10] [11] . For easier handling, sterilization and scale-up, the fixed bed can be integrated to the conditioning vessel, making it a more compact unit. This type of reactor has been built upto 25 L of fixed bed volume.
Due to low shear stress, immobilization promotes the application of serum-or protein-free medium. It allows an easier medium exchange and reduces the steps of downstream processing. With a simple, and easy-to-handle reactor design, fixed bed reactor systems enable a high volume specific cell density (10 8 cells mL -1 ) and productivity for the production of biopharmaceuticals over long periods of time (see below). Of special importance is the improved culture stability through immobilization [12] [13] [14] [15] .
CARRIERS
Immobilization occurs when organisms are entrapped in the interstices of porous particles or within gels and membranes. Carriers can be divided into two main groups-organic and inorganic. Suitable carriers for the immobilization of animal cells must fulfill certain requirements such as high surface to volume ratio, simple and non-toxic immobilization, optimal diffusion from the bulk phase to the center of the carrier, mechanical stability and pH stability. They should be steam sterilisable, reusable and suitabile for adherent and non-adherent cells.
A large number of macroporous carriers and support materials for immobilization have been suggested, including glass (natron, borosilicate) [13, [16] [17] [18] [19] [20] [21] , collagen [22] , synthetic materials, e.g. polypropylene, polyurethane [23] [24] [25] [26] [27] [28] [29] [30] [31] or ceramics [own data, not published]. Most of these carriers proved to be suitable for a large number of cell types (e.g. hybridoma, CHO, hepatocytes etc., compare Fig. 2) . In some cases (e.g. carriers made of glass or cellulose) coating with gelatine was recommended to support growth of strictly adherent cells [18, unpublished data] .
The properties of the cells and the mode of cultivation carried out defines the type of carrier to be chosen. Thus, carriers of diameters below 0.3 mm (microcarriers) are used mainly for the cultivation of adherent cells in suspension, carriers between 0.3 and 1 mm are appropriate for fluidized-beds, and those sizes above 1 mm are used in fixed-bed systems. 
APPLICATIONS AND DESIGN CRITERIA Overview
Fixed bed reactors have been successfully used for a wide range of cell lines and their applications. Whereas the earlier studies focused on the production of biopharmaceuticals as an alternative to suspension reactors or hollow fiber systems, new applications can be found in other areas including gene and cell therapy and tissue engineering. Some of the recent developments in fixed bed reactor technology are presented in Table 1 .
Fixed Bed Cultivation at Increased Oxygen Levels
The heterogeneity inside the carriers, i.e. the nutrient, metabolite and biomass concentration gradients along the radius of the carrier can limit productivity. These gradients are due to the substrate or oxygen consumption of the immobilized cells. If the diffusion rate of an important substrate into the carrier is slow compared to the reaction rate, limitation might occur. The opposite can happen with products which accumulate to inhibiting concentrations inside the carrier (e.g. carbon dioxide). Fassnacht and Pörtner [33] used an oxygen reaction-diffusion model to describe and optimize the performance of axial-flow as well as radial-flow fixedbeds. Furthermore, they could show that an increased oxygen level can significantly improve the performance of a fixed bed reactor. A 100 mL fixed-bed reactor was operated with a hybridoma cell line at high dilution rates between 10 and 20 L medium per L of fixed-bed volume per day. At these extremely high perfusion rates, the volume specific glucose uptake rate as well as the production rate of monoclonal antibodies were upto two times higher than when the medium was sparged with 21, 42 or 63 % oxygen enriched air. Although dissolved oxygen concentrations higher than air saturation are usually considered to be toxic for animal cells in suspension cultures [46] , it was found that this was not the case for fixed bed systems.
Cultivation of Hepatocytes
In order to develop a bioartificial liver (BAL), many authors have attempted to optimize hepatocyte cultures at air/O +CO high cell densities in different cultivation systems trying to mimic tissue-like growth (compare Table 1 ). However, compared to cell lines with higher adaptability to culture such as hybridomas and other cell lines, hepatocytes are considered to be one of the most difficult cell types to be cultivated in an artificial environment.
The fact that the human hepatocellular carcinoma cell lines like Hep-G2 secrete the major plasma proteins and the hepatitis B surface antigen, has directed the attention towards these cell lines for research purposes. They have a potential use in screening systems, where cultures of these cells are subjected to the effects of different substances such as new drugs or toxic metabolites. The future of these techniques is the partial replacement of animal and clinical trials, in which the complicated process of blood screening and ethics during research are of major importance, by culture systems of human cells.
An example for fixed bed cultivation of the hepatoblastoma cell line Hep-G2 is shown in Fig. (3) , where different culture conditions were applied during 24 days of cultivation. Continuous perfusion of medium in the conditioning vessel was started when glucose became limiting. A higher glutamine concentration marginally increased the substrate uptake rate during continuous culture. An oxygen supply at 200% air saturation and a dilution rate of D FB = 8 d -1 after 20 days of culture significantly increased the substrate consumption rates. This successful example underlines again the importance of proper selection of process parameters such as perfusion rates and oxygen level.
Production of Retroviral Vectors for Somatic Gene Therapy
A number of examples of successful application of fixed bed reactors for the production of high titer retroviral vectors for gene therapy can be found in the literature (compare . (3) . Cultivation of the Hep-G2 in a 100 mL axial-flow fixedbed reactor. Top: Glucose ( ), lactate ( ) and glutamine ( ) concentrations as well as the relative oxygen percentage at the air inlet ( ). Bottom: Glucose uptake rate ( ) and the lactate production rate ( ) during the culture. The vertical lines indicate the different dilution rates and conditions during the 24 days of culture. FB: fixed bed. these obstacles, the kinetic relations of the bioreaction, cell growth and vector production in different culture modes need to be understood. Furthermore, not only generic optimization of the packaging cell line and the vector stability needs to be studied, but also the effective optimization of process modes.
Nehring et al. [28] used a mathematical model developed on the basis of experimental data measured in culture dishes. The kinetics of cell growth, nutrient consumption and vector production and decay was applied to analyse different process modes and to optimize the cultivation and harvest strategy during fixed bed operation. The optimization with the aid of the model led to the conclusion that optimizing the harvest cycles and feed flows resulted in a higher yield in comparison to batch or fed batch modes.
Retroviral pseudotype vectors derived from the murine leukaemia virus carrying the HIV-1 envelop protein MLV (HIV-1) were produced using a 200ml fixed bed reactor for high cell density cultivation on macro-porous carriers. Reasonable optimal parameters calculated with the help of the model were applied to run the cultivation. After starting the cultivation in batch mode, the reactor was either run in perfusion, perfused fed-batch or repeated-batch. The different culture modes are compared in Table 2 . Whereas the highest maximal end point titer was measured in perfusion mode, the highest medium related productivity was achieved in repeated batch mode. Sensitivity analysis performed based on the results of the optimization showed that under optimal conditions, the final concentration and the yield of the entire process is more sensitive to the parameters of process operation than to the bioreaction due to the fast degradation of replication competent pseudo-type vectors.
Scale-Up
Scale-up is a major demand for high-yield stable bioprocess systems in mammalian cell culture-based biopharmaceutical production processes [32, 33, 35, 47] . Using the concept of a radial flow geometry, Fassnacht and Pörtner [33] demonstrated a scale-up from 100 mL to 5 L of fixed bed volume. As perfusion rates of 10 L medium per L of fixed-bed volume per day correspond to a medium flow rate of approx. 50 L per day for a 5 L-reactor, this reactor size can be regarded as pilot scale. Further optimization of the fixed bed process can be achieved by reducing the inoculum volume [8] . For this, it is crucial to reduce the initial cell density to a minimum without affecting exponential growth as well as to increase the bed volume in the reactor during the fermentation process. The combination of a low celldensity inoculum and a cultivation strategy where the surface area for cell growth can be increased progressively might reduce the number of pre-culture steps needed before starting up a cell culture process. Inoculation means not only the cell density to be inoculated, but also the working volume of the reactor to be inoculated. From batch cultures performed in a 10 mL fixed-bed reactor, a cell density of 5·10 4 cells mL -1 of medium volume was obtained as an optimal value with respect to growth rate within the fixed bed (own data, not published). In suspension culture, usually 1-2 10 6 cells mL -1 are required.
To further reduce the inoculum volume in fixed-bed reactor, the "Inoculation during Cultivation" strategy can be applied. This strategy consists of partially filling the conditioning vessel with medium at the beginning of the cultivation where only a fraction of the fixed-bed is submerged and therefore active. Only this submerged part of the fixed-bed is then inoculated with a low initial cell density. After a short cultivation period the initial cell density is increased and the medium level within the conditioning vessel is raised to another desired height. This activates the fresh part of the fixed-bed which is then inoculated by the low number of cells that are washed out of the carriers during cultivation. The maximal cell density is then finally reached during the culture.
This strategy was successfully applied in a 5.6 L radial flow fixed-bed reactor. The start-up phase was divided into three steps with each step covering one third of the fixed-bed in the reactor. With a very low initial cell density of 5 10 4 cells mL -1 (harvested from 2 roller bottles) for the type of fixed bed reactor used, it was possible to start the cultivation. The reactor has already been operated at cell densities higher than 5·10 7 cells mL -1 of fixed bed volume, which is an increase in cell density of more than 1300 folds. This is at least one order higher compared to suspension reactors run in fedbatch or continuous perfusion modes. Therefore, with this pilot scale reactor system, a significant reduction of the preinoculation steps was achieved. The reduction of the number of cells to be inoculated into a fixed bed reactor by means of the optimization of the initial cell density and by means of scaling-up strategies will lead to the reduction of the inoculation steps during the cultivation cascades in industrial processes.
CONCLUSIONS
Fixed bed reactors have underlined their potential for the cultivation of mammalian cells for a large number of applications ranging from the production of biopharmaceuticals to tissue engineering and gene therapy. With respect to produc- tion of biopharmaceuticals, advantages can be seen in (i) high volume specific cell density, (iii) high volume specific productivity during long-term cultures, (iii) low shear forces, (iv) simple medium exchange and cell / product separation, (v) simple scale-up with radial-flow geometry. Compared to suspension reactors which are still the preferred type of reactor system on industrial scale, fixed bed reactors can be regarded as reliable, multipurpose production systems. Whereas the cultivation of production cell lines in suspension often requires extensive optimization of medium and cell line (e.g. tolerance to shear stress) or process conditions (stirrer speed, aeration rate), most cell lines can be cultivated in fixed bed reactors without further adaptation. Therefore, advantages of this technology can especially be seen in those cases, where non optimized cell lines or media are applied (e.g. for production of small quantities of product for cell line selection or clinical trials). A further advantage can also be seen in the reduced pre-culture steps compared to suspension reactors.
Applications in the field of tissue engineering and gene therapy, where usually adherent cells are used and tissue like structures are required, will further promote the use of fixed bed reactors.
